chartexchange

Randomized Study of Non-Invasive Autonomic Neuromodulation for Long COVID Published Online in Neuromodulation

GlobeNewswire Inc. | Nov 12, 2026 8:00 AM EST

Randomized, open-label, hypothesis-generating study (541 participants enrolled; 250 met final analysis criteria) evaluated two proprietary non-invasive neuromodulation technologies, electroCore’s cervical vagus nerve stimulation and Sonocea Sonic Augmentation Technology™ (SAT) Randomized, open-label, hypothesis-generating study (541 participants enrolled; 250 met final analysis criteria) evaluated two proprietary non-invasive neuromodulation technologies, electroCore’s cervical vagus nerve stimulation and Sonocea Sonic Augmentation Technology™ (SAT)

Read original article